Fig. 5From: An international survey of healthcare providers’ knowledge of cardiac complications of cancer treatmentsResponses to clinical scenario #2: A 58 year old male is receiving adjuvant infusional 5-fluorouracil during cycle 2 for resected stage III colorectal carcinoma. He develops sudden chest pain and nausea, and presents to the emergency department. A 12 lead electrocardiogram reveals inferior ST segment elevation. He is managed medically with complete resolution of symptoms. A subsequent angiogram reveals no evidence of coronary artery disease. A follow-up echocardiogram reveals an ejection fraction of 58%. What would you now recommend for adjuvant chemotherapy?Back to article page